AKO-B vs PG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a deeply concerning Piotroski F-Score of 0/9, indicating severe financial health weaknesses, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite this, the company demonstrates strong profitability with a 24.73% ROE and solid 36.3% YoY earnings growth, supported by a robust 4.41% dividend yield and 70% dividend strength. Valuation appears mixed: trading at a P/E of 16.44 below sector average, yet far above the Graham Number of $224.66 when adjusted for currency context, suggesting potential overvaluation. Technical trend is weak at 10/100, and insider sentiment is lukewarm, offsetting strong recent price performance (+67.2% 1Y).
PG shows neutral fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
AKO-B vs PG: Head-to-Head Comparison
This page compares Embotelladora Andina S.A. (AKO-B) and The Procter & Gamble Company (PG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.